Colistin distribution in the peritoneal fluid of a patient with severe peritonitis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 4035-4036

  Mimoz, Olivier ^a   Petitpas, Franck ^a   Grégoire, Nicolas ^b   Gobin, Patrice ^c   Marchand, Sandrine ^c   Couet, William ^c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIMETHATE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; AGED; ANTIBIOTIC THERAPY; CASE REPORT; COLON CARCINOMA; COLON RESECTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI INFECTION; HUMAN; KIDNEY CLEARANCE; LETTER; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; PERITONEAL FLUID; PRIORITY JOURNAL; PSEUDOMONAS INFECTION;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; COLISTIN; HUMANS; MALE; PERITONITIS;

EID: 84862551794     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00478-12     Document Type: Letter

References (10)

1. Couet W, et al. 2011. Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers. Clin. Pharmacol. Ther. 89:875-879.
2. Couet W, Gregoire N, Marchand S, Mimoz O. 2012. Colistin pharmacokinetics: the fog is lifting. Clin. Microbiol. Infect. 18:30-39.
3. Dahyot-Fizelier C, et al. 2010. Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis. Clin. Pharmacokinet. 49:323-334.
4. Garonzik SM, et al. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother. 55:3284-3294.
5. Gobin P, Lemaitre F, Marchand S, Couet W, Olivier JC. 2010. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Antimicrob. Agents Chemother. 54:1941-1948.
6. Gregoire N, et al. 2011. Population pharmacokinetic study of colistin in combined healthy volunteers and patients with severe Gram-negative multidrug-resistant infections, poster P804. 21st ECCMID, Milan, Italy.
7. Karjagin J, et al. 2008. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin. Pharmacol. Ther. 83:452-459.
8. Li J, et al. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
9. Plachouras D, et al. 2009. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob. Agents Chemother. 53:3430-3436.
10. Vincent JL, et al. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329.